Ownership stake disclosure by Atlas Venture Fund X, L.P. (amended)
Atlas Venture Fund X, L.P., filed by
GBIO
Generation Bio Co. SEC filings
Every EDGAR filing for Generation Bio Co. (GBIO), newest first, with AI summaries and stories.
- Ticker
- GBIO
- CIK
- 1733294
- Latest filing
- May 14
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINESCHEDULE 13G/AGeneration Bio Co.GBIOLIVE ROUTINE15-12GGeneration Bio Co.GBIOLIVE ROUTINESCHEDULE 13G/AGeneration Bio Co.GBIOLIVE Ownership stake disclosure by PRICE T ROWE ASSOCIATES INC /MD/ (amended)
PRICE T ROWE ASSOCIATES INC /MD/, filed by
ROUTINESCHEDULE 13G/AGeneration Bio Co.GBIOLIVE Ownership stake disclosure by RENAISSANCE TECHNOLOGIES LLC (amended)
RENAISSANCE TECHNOLOGIES LLC, filed by
ROUTINESCHEDULE 13G/AGeneration Bio Co.GBIOLIVE Ownership stake disclosure by Baselake Partners, LP (amended)
Baselake Partners, LP, filed by
ROUTINEEFFECTGeneration Bio Co.GBIOLIVE ROUTINE4Generation Bio Co.GBIOLIVE 13 insider filings
Atlas Venture Fund X, L.P., insider filing for GBIO
Show all 13
- 4Insider filing for GBIO
- 4Insider filing for GBIO
- 4Insider filing for GBIO
- 4Insider filing for GBIO
- 4Insider filing for GBIO
- 4Insider filing for GBIO
- 4Insider filing for GBIO
- 4Insider filing for GBIO
- 4Insider filing for GBIO
- 4Insider filing for GBIO
- 4Insider filing for GBIO
- 4Insider filing for GBIO
- 4Insider filing for GBIO
Atlas Venture Fund X, L.P., reporting · Atlas Venture Associates X, LLC, reporting · +4 more
ROUTINEPOS AMGeneration Bio Co.GBIOLIVE ROUTINES-8 POSGeneration Bio Co.GBIOLIVE ROUTINES-8 POSGeneration Bio Co.GBIOLIVE ROUTINES-8 POSGeneration Bio Co.GBIOLIVE ROUTINES-8 POSGeneration Bio Co.GBIOLIVE ROUTINES-8 POSGeneration Bio Co.GBIOLIVE ROUTINES-8 POSGeneration Bio Co.GBIOLIVE ROUTINES-8 POSGeneration Bio Co.GBIOLIVE ROUTINE8-KGeneration Bio Co.GBIOLIVE ROUTINESC 14D9/AGeneration Bio Co.GBIOLIVE ROUTINESC TO-T/AGeneration Bio Co.GBIOLIVE XOMA Royalty Corp, filed by
NOTABLE25-NSEGeneration Bio Co.GBIOLIVE Nasdaq Stock Market LLC, filed by
ROUTINESCHEDULE 13GGeneration Bio Co.GBIOLIVE Ownership stake disclosure by Baselake Partners, LP
Baselake Partners, LP, filed by
ROUTINE4Generation Bio Co.GBIOLIVE 3 insider filings
Yalonda Howze, insider filing for GBIO
Show all 3
- 4Insider filing for GBIO
- 4Insider filing for GBIO
- 4Insider filing for GBIO
Yalonda Howze, reporting
ROUTINESC TO-T/AGeneration Bio Co.GBIOLIVE XOMA Royalty Corp, filed by
ROUTINESC 14D9/AGeneration Bio Co.GBIOLIVE ROUTINE4Generation Bio Co.GBIOLIVE 3 insider filings
Yalonda Howze, insider filing for GBIO
Show all 3
- 4Insider filing for GBIO
- 4Insider filing for GBIO
- 4Insider filing for GBIO
Yalonda Howze, reporting
ROUTINESC TO-T/AGeneration Bio Co.GBIOLIVE XOMA Royalty Corp, filed by
NOTABLESC 14D9Generation Bio Co.GBIOLIVE NOTABLESC TO-TGeneration Bio Co.GBIOLIVE XOMA Royalty Corp, filed by
ROUTINESC14D9CGeneration Bio Co.GBIOLIVE ROUTINE8-KGeneration Bio Co.GBIOLIVE ROUTINE4Generation Bio Co.GBIOLIVE Generation Bio Co. - Insider ownership filing (4)
- Insider ownership filing (4)
- Reports beneficial ownership changes
Geoff Mcdonough, reporting
ROUTINESCHEDULE 13G/AGeneration Bio Co.GBIOLIVE Ownership stake disclosure by SymBiosis Capital Partners, LLC (amended)
SymBiosis Capital Partners, LLC, filed by
ROUTINESCHEDULE 13GGeneration Bio Co.GBIOLIVE 2 13G filings
Ownership stake disclosure by SymBiosis Capital Partners, LLC
Show all 2
- SCHEDULE 13GOwnership stake disclosure
- SCHEDULE 13G/AOwnership stake disclosure (amended)
SymBiosis Capital Partners, LLC, filed by
ROUTINESCHEDULE 13GGeneration Bio Co.GBIOLIVE This Schedule 13G filing discloses that Renaissance Technologies LLC has acquired a 5.1% passive stake in Generation Bio Co. (GBIO), a clinical-stage genetic medicines company.
RENAISSANCE TECHNOLOGIES LLC, filed by